Bristol-Myers Squibb buy UBS Group AG
Start price
07.01.26
/
50%
€47.50
Target price
07.01.27
€55.55
Performance (%)
15.94%
Price
20:16
€55.07
Summary
This prediction is currently active. The prediction currently has a performance of 15.94%. This prediction currently runs until 07.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | 2.862% | 2.862% |
| iShares Core DAX® | 0,85 % | 0,39 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % |
| iShares S&P 500 | 0,06 % | 0,78 % |
Comments by UBS_Group_AG for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $65.00 price target on the stock.
Ratings data for BMY provided by MarketBeat